Intensity modulated radiation therapy after extra-pleural pneumonectomy for malignant pleural mesothelioma is feasible without fatal pulmonary toxicity and provides good survival.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To analyze patterns of failure, toxicity, relapse-free survival (RFS), and overall survival (OS) in malignant pleural mesothelioma (MPM) patients treated with intensity-modulated radiation therapy following extrapleural pneumonectomy (EPP).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Asia Pac J Clin Oncol

Title: Asia-Pacific journal of clinical oncology

Publisher: Wiley

ISSN (Electronic): 1743-7563

ISSN (Print): 1743-7555

Publication date (Electronic): Apr 2018

Volume: 14

Issue: 2

Affiliations

[1 ] Department of Radiation Oncology, Baylor Scott and White Health, Temple, Texas, USA.

[2 ] Biostatistics, Baylor Scott and White Health, Temple, Texas, USA.

[3 ] Hematology and Oncology, Baylor Scott and White Health, Temple, Texas, USA.

[4 ] Radiation Oncology, Austin Cancer Centers, Texas, USA.

Article

DOI: 10.1111/ajco.12680

PubMed ID: 28371288

SO-VID: 46bc9f05-7264-451b-bccb-b962b1ff9186

History

Keywords: extra pleural pnemonectomy,intensity modulated radiation therapy,malignant pleural mesothelioma

Data availability:

Keywords: extra pleural pnemonectomy, intensity modulated radiation therapy, malignant pleural mesothelioma

Comments

Comment on this article

scite_

0

Smart Citations

0

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Cited by 3

See all cited by